Eplerenone – Effects, Dosage and Side Effects
Eplerenone is a prescription medication belonging to the class of aldosterone antagonists, used in the treatment of heart failure and high blood pressure.
Things worth knowing about "Eplerenone"
Eplerenone is a prescription medication belonging to the class of aldosterone antagonists, used in the treatment of heart failure and high blood pressure.
What is Eplerenone?
Eplerenone is a selective aldosterone antagonist classified as a potassium-sparing diuretic. It works by blocking the mineralocorticoid receptor, thereby preventing the hormone aldosterone from exerting its effects in the body. Eplerenone is available as a prescription-only medicine and is approved in Europe and the United States under various brand names.
Indications
Eplerenone is used in the following conditions:
- Heart failure following a myocardial infarction (heart attack) – to reduce the risk of death in patients with reduced left ventricular function
- Chronic heart failure with reduced ejection fraction (HFrEF) as part of a comprehensive treatment regimen
- Essential hypertension (high blood pressure), particularly when other treatments are insufficient
Mechanism of Action
Aldosterone is a hormone produced by the adrenal cortex that promotes sodium and water retention in the kidneys while causing potassium excretion. Excess aldosterone can contribute to high blood pressure, cardiac fibrosis, and ventricular hypertrophy (thickening of the heart muscle).
Eplerenone selectively binds to the mineralocorticoid receptor and blocks its activation by aldosterone. Compared to the older drug spironolactone, eplerenone has a higher selectivity for this receptor and has minimal affinity for androgen or progesterone receptors. This significantly reduces hormone-related side effects such as gynecomastia (breast tissue growth in men).
Blocking the mineralocorticoid receptor results in:
- Reduced sodium and water reabsorption in the kidneys
- Increased potassium retention (potassium-sparing effect)
- Lowering of blood pressure
- Protection of the heart muscle against fibrotic remodeling (cardioprotection)
Dosage
The dosage of eplerenone depends on the indication and the patient's kidney function:
- Post-myocardial infarction / Heart failure: Treatment is typically started at 25 mg once daily, increasing to 50 mg once daily after 4 weeks, provided serum potassium levels allow.
- Hypertension: Standard starting dose is 50 mg once daily, which may be increased to 50 mg twice daily if needed.
Eplerenone is taken as a tablet and can be taken with or without food. The exact dose is determined by the treating physician.
Side Effects
Eplerenone is generally well tolerated. Possible side effects include:
- Hyperkalemia (elevated potassium levels in the blood) – especially in patients with reduced kidney function or those taking other potassium-raising agents
- Dizziness and headache
- Elevated creatinine and urea levels (indicating changes in kidney function)
- Fatigue and weakness
- Rarely: gynecomastia (much less common than with spironolactone)
Regular monitoring of potassium levels and kidney function is essential during treatment with eplerenone.
Contraindications
Eplerenone must not be used in patients with:
- Pre-existing hyperkalemia (elevated blood potassium)
- Severe renal insufficiency
- Concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole)
- Concomitant use of other potassium-sparing diuretics or potassium supplements
Drug Interactions
Eplerenone is metabolized in the liver by the enzyme CYP3A4. Medications that inhibit or induce this enzyme can increase or decrease the effects of eplerenone. Particular caution is required with:
- ACE inhibitors and angiotensin receptor blockers (increased risk of hyperkalemia)
- Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen
- Lithium (risk of increased lithium toxicity)
Important Notes on Use
Eplerenone is a prescription-only medication and must only be taken under medical supervision. Regular blood tests (potassium levels, kidney function) are essential to detect potential adverse effects early. Patients should inform their doctor about all other medications, dietary supplements, and existing medical conditions.
References
- European Medicines Agency (EMA): Eplerenone – Product Information and Assessment Report. www.ema.europa.eu
- Pitt B et al. – Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine, 2003; 348(14):1309–1321.
- Zannad F et al. – Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms (EMPHASIS-HF). New England Journal of Medicine, 2011; 364(1):11–21.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMost read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Eplerenone-en